Search Results
Search for other papers by Marika Bogdani in
Google Scholar
PubMed
Search for other papers by Angela M Henschel in
Google Scholar
PubMed
Search for other papers by Sanjay Kansra in
Google Scholar
PubMed
Search for other papers by Jessica M Fuller in
Google Scholar
PubMed
Search for other papers by Rhonda Geoffrey in
Google Scholar
PubMed
Search for other papers by Shuang Jia in
Google Scholar
PubMed
Search for other papers by Mary L Kaldunski in
Google Scholar
PubMed
Search for other papers by Scott Pavletich in
Google Scholar
PubMed
Search for other papers by Simon Prosser in
Google Scholar
PubMed
Search for other papers by Yi-Guang Chen in
Google Scholar
PubMed
Search for other papers by Åke Lernmark in
Google Scholar
PubMed
Search for other papers by Martin J Hessner in
Google Scholar
PubMed
Introduction Type 1 diabetes (T1D) is an autoimmune disease characterized by immunocyte infiltration of the pancreatic islets (insulitis) and destruction of the insulin-secreting β cells. Diabetes in the biobreeding (BB) rat exhibits many
Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
Search for other papers by Wenpeng Dong in
Google Scholar
PubMed
Search for other papers by Ye Jia in
Google Scholar
PubMed
Search for other papers by Xiuxia Liu in
Google Scholar
PubMed
Search for other papers by Huan Zhang in
Google Scholar
PubMed
Search for other papers by Tie Li in
Google Scholar
PubMed
Search for other papers by Wenlin Huang in
Google Scholar
PubMed
Search for other papers by Xudong Chen in
Google Scholar
PubMed
Search for other papers by Fuchun Wang in
Google Scholar
PubMed
Search for other papers by Weixia Sun in
Google Scholar
PubMed
Department of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, Jilin, People’s Republic of China
Search for other papers by Hao Wu in
Google Scholar
PubMed
Introduction As one of the long-term complications of diabetes, diabetic nephropathy (DN) is the main cause of end-stage renal disease ( Dronavalli et al . 2008 ). Thus, end-stage renal disease cannot be effectively prevented or treated
Search for other papers by Qiaoli Cui in
Google Scholar
PubMed
Search for other papers by Yijing Liao in
Google Scholar
PubMed
Search for other papers by Yaojing Jiang in
Google Scholar
PubMed
Search for other papers by Xiaohang Huang in
Google Scholar
PubMed
Search for other papers by Weihong Tao in
Google Scholar
PubMed
Search for other papers by Quanquan Zhou in
Google Scholar
PubMed
Search for other papers by Anna Shao in
Google Scholar
PubMed
Search for other papers by Ying Zhao in
Google Scholar
PubMed
Search for other papers by Jia Li in
Google Scholar
PubMed
Search for other papers by Anran Ma in
Google Scholar
PubMed
Search for other papers by Zhihong Wang in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Zunyuan Yang in
Google Scholar
PubMed
Search for other papers by Yinan Liang in
Google Scholar
PubMed
Search for other papers by Minglin Wu in
Google Scholar
PubMed
Search for other papers by Zhenyan Yang in
Google Scholar
PubMed
Search for other papers by Wen Zeng in
Google Scholar
PubMed
Shanghai Yinuo Pharmaceutical Co., Ltd., Shanghai, China
Keenan Research Centre for Biomedical Science, Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto, Ontario, Canada
Search for other papers by Qinghua Wang in
Google Scholar
PubMed
methods Animals Male rhesus monkeys with spontaneous type 2 diabetes were provided and housed in Sichuan Primed Shines Bio-tech Co., Ltd. (SPSB). Before the experiments, the animals were quarantined and received a physical examination, two
Search for other papers by Kanta Kon in
Google Scholar
PubMed
Search for other papers by Hiroshi Tsuneki in
Google Scholar
PubMed
Search for other papers by Hisakatsu Ito in
Google Scholar
PubMed
Search for other papers by Yoshinori Takemura in
Google Scholar
PubMed
Search for other papers by Kiyofumi Sato in
Google Scholar
PubMed
Search for other papers by Mitsuaki Yamazaki in
Google Scholar
PubMed
Search for other papers by Yoko Ishii in
Google Scholar
PubMed
Search for other papers by Masakiyo Sasahara in
Google Scholar
PubMed
Search for other papers by Assaf Rudich in
Google Scholar
PubMed
Search for other papers by Takahiro Maeda in
Google Scholar
PubMed
Search for other papers by Tsutomu Wada in
Google Scholar
PubMed
Search for other papers by Toshiyasu Sasaoka in
Google Scholar
PubMed
Introduction The prevalence of lifestyle-related disorders, including insomnia, obesity and type 2 diabetes is increasing worldwide, mainly due to dramatic changes in living environments in modern society. Evidence indicates that environmental
Search for other papers by P Brandimarti in
Google Scholar
PubMed
Search for other papers by J M Costa-Júnior in
Google Scholar
PubMed
Search for other papers by S M Ferreira in
Google Scholar
PubMed
Search for other papers by A O Protzek in
Google Scholar
PubMed
Search for other papers by G J Santos in
Google Scholar
PubMed
Search for other papers by E M Carneiro in
Google Scholar
PubMed
Search for other papers by A C Boschero in
Google Scholar
PubMed
Search for other papers by L F Rezende in
Google Scholar
PubMed
Introduction Type 2 diabetes is a complex illness mainly characterized by hyperglycemia, usually accompanied by pancreatic islets malfunction, and reduced insulin sensitivity, as well as lower insulin clearance. Although hyperglycemia is one of the
Search for other papers by Paul Millar in
Google Scholar
PubMed
Search for other papers by Nupur Pathak in
Google Scholar
PubMed
Search for other papers by Vadivel Parthsarathy in
Google Scholar
PubMed
Search for other papers by Anthony J Bjourson in
Google Scholar
PubMed
Clinical Chemistry Laboratory, Western Health and Social Care Trust, Altnagelvin Hospital, Northern Ireland, UK
Search for other papers by Maurice O’Kane in
Google Scholar
PubMed
Search for other papers by Varun Pathak in
Google Scholar
PubMed
Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is a metabolic disorder that arises due to a complex array of molecular defects manifesting in dysregulated insulin secretion, impaired insulin action or both. Since the pathophysiology of T2DM is
Search for other papers by Xiaoyi Ma in
Google Scholar
PubMed
Search for other papers by Fei Gao in
Google Scholar
PubMed
Search for other papers by Qi Chen in
Google Scholar
PubMed
Search for other papers by Xiuping Xuan in
Google Scholar
PubMed
Search for other papers by Ying Wang in
Google Scholar
PubMed
Search for other papers by Hongjun Deng in
Google Scholar
PubMed
Search for other papers by Fengying Yang in
Google Scholar
PubMed
Search for other papers by Li Yuan in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is characterized by progressive beta-cell dysfunction. In recent years, the incidence of prediabetes and T2DM has steadily increased ( Kehlenbrink et al . 2019 ). Moreover, the incidence of
Search for other papers by Mari van de Vyver in
Google Scholar
PubMed
. 2023 ). Figure 1 Factors contributing to chronic inflammation in type 2 diabetes. Continuous activation signals are derived from multiple sources including, dysfunctional adipose tissue, the aberrant metabolic activation of leukocytes, damage
Search for other papers by Sarah L Craig in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
Search for other papers by Gerd Hamscher in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction Dipeptidyl peptidase-4 (DPP-4) inhibitors are an orally available class of drugs, clinically approved for the treatment of type 2 diabetes mellitus (T2DM) ( Scott 2017 ). The primary therapeutic benefit of DPP-4 inhibitors in T2DM
Search for other papers by Vanesa Jiménez-Amilburu in
Google Scholar
PubMed
Search for other papers by Susanne Jong-Raadsen in
Google Scholar
PubMed
Search for other papers by Jeroen Bakkers in
Google Scholar
PubMed
Search for other papers by Herman P Spaink in
Google Scholar
PubMed
Search for other papers by Rubén Marín-Juez in
Google Scholar
PubMed
glycemic control present one of the main risk factors for developing heart failure ( Haslam & James 2005 ). Specially, type 2 diabetes (T2D) is strongly associated with heart failure ( Bell 2003 a ). Patients with T2D present an increased incidence of heart